Noted: Insulete was founded and is headed by Hans Solinger, a well-known transplant surgeon and University of Wisconsin-Madison researcher who has helped bring pharmaceutical drugs to market. Sollinger and Tausif Alam, Insulete’s chief financial officer, discovered and patented a DNA sequence that is glucose responsive and promotes the activation of the human insulin gene.
Office of Strategic Communication